Announced Mon, 29 Jun · 16:36 IST
Trading Window Closure for Q1 FY27 (quarter ended June 30, 2026)
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹224.00
prior close
₹225.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.5+5.4+15.2+27.2+24.1+13.4+16.1———
Up moveDown movePending
AI summary
Samrat Pharmachem has informed BSE that the trading window for its shares will remain closed for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026. This is a routine compliance step under SEBI Insider Trading Regulations to prevent dealing in shares while in possession of unpublished price sensitive information ahead of the quarterly results.
Likely market impact
Routine SEBI compliance; no material impact on shareholders. Signals that Q1 FY27 results are due soon.